210-Day follow-up of the RAVEL study: a randomized study with the sirolimus-eluting Bx VELOCITY™ balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions
- 6 March 2002
- journal article
- abstracts
- Published by Elsevier in Journal of the American College of Cardiology
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: